FDA Drug Recalls

Recalls / Class II

Class IID-66014-001

Product

Extended Phenytoin Sodium Capsules, USP, 100 mg, 1000 CAPSULES, Rx only, amneal PHARMACEUTICALS label, NDC 65162-212-11 --- Manufactured by: Amneal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Amneal Pharmaceuticals Glasgow, KY 42141

Brand name
Extended Phenytoin Sodium
Generic name
Phenytoin Sodium
Active ingredient
Phenytoin Sodium
Route
Oral
NDC
65162-212
FDA application
ANDA040765
Affected lot / code info
Batch/Lot HL50611, exp. 1/2014

Why it was recalled

Failed dissolution specifications; 18 month CRT

Recalling firm

Firm
Amneal Pharmaceuticals of New York, LLC.
Manufacturer
Amneal Pharmaceuticals LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
85 Adams Avenue, N/A, Hauppauge, New York 11788

Distribution

Quantity
895 - 1000 count bottles
Distribution pattern
IL, NH, NJ, NY, OH, RI, TN

Timeline

Recall initiated
2013-08-17
FDA classified
2013-11-04
Posted by FDA
2013-11-13
Terminated
2014-07-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-66014-001. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Extended Phenytoin Sodium · FDA Drug Recalls